Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death

NCT06856993 is registered in ClinicalTrials.gov with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.

NCT NCT06856993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06856993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
Lead sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase
Observational
Overall status
Recruiting
Start date
December 22, 2021
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical prognosis, exosome multiomics, sudden cardiac death